SNT 3.45% 3.0¢ syntara limited

Ann: Pharmaxis Announces Positive Combined Phase , page-10

  1. 1,571 Posts.
    re: Ann: Pharmaxis Announces Positive Combine... Interesting the comparison to rhdnase the main product on the market and the upside benefits! Surprised there has not been more chat on here about it.

    Does anyone know whether there are any comparisons though to other phase 3 drugs that have either been approved recently or about to be approved?
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.001(3.45%)
Mkt cap ! $35.82M
Open High Low Value Volume
2.9¢ 3.0¢ 2.8¢ $49.35K 1.726M

Buyers (Bids)

No. Vol. Price($)
1 100000 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 709077 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.